Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Vote in favor of the bloom plan that adds a bit of excellence to your life! - 2Bitcoin momentum builds in Abu Dhabi as global interest surges
- 3Video Conferencing Instruments for Virtual Gatherings
- 4Supportive Tips On Home loans For First-Time Home Purchasers
- 5Finding the Force of Mentorship: Self-awareness Through Direction
- True serenity: Investigating Emotional well-being and the Advantages of Contemplation
- How federal officials talk about health is shifting in troubling ways – and that change makes me worried for my autistic child
- COGAT discovers motor oil hidden inside UN's humanitarian aid to Gaza in smuggling attempt
- Wellness Bits of knowledge Readily available: A Survey of \Following Wellbeing and Progress\ Wellness Wearables
- IDF strikes terror infrastructure across Iran, attack reported on Kashan airport
- Palestinians protest against Israel's new death penalty law
- The Most Important Crossroads in Olympic History
- Best Amusement Park in Europe: Where Do You Very much want to Visit?
- Timothy Busfield turns himself in to face child sexual abuse charges in New Mexico
